HERANTIS PHARMA
IPOFounded 2008 · $18.6M raised
- Founded
- 2008
- Business Model
- B2B
- Website
- herantis.com
- Total Funding
- $18.6M
- Last Round
- $5.2M Venture RoundFeb 2026
- Rounds
- 3
About
Clinical-stage biotechnology disease modifying therapies for neurodegenerative diseases.
Summary
HERANTIS PHARMA is a Biotech company, founded in 2008. It has raised $18.6M in total across 3 rounds, most recently a $5.2M Venture Round round in Feb 2026. Investors include European Innovation Council Fund.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company